Serum 25-hydroxyvitamin D values and risk of incident cardiovascular disease: A population-based retrospective cohort study

被引:11
作者
Dudenkov, Daniel, V [1 ]
Mara, Kristin C. [2 ]
Maxson, Julie A. [3 ]
Thacher, Tom D. [3 ]
机构
[1] Mayo Clin, Dept Internal Med, Jacksonville, FL 32224 USA
[2] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[3] Mayo Clin, Dept Family Med, Rochester, MN USA
基金
美国国家卫生研究院;
关键词
Vitamin D; Cardiovascular disease; Epidemiology; Public health; MEDICAL-RECORDS LINKAGE; VITAMIN-D DEFICIENCY; SUPPLEMENTATION; SURVIVAL; HISTORY;
D O I
10.1016/j.jsbmb.2021.105953
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Concentrations of serum 25-hydroxyvitamin D [25(OH)D] below 20 ng/mL and above 50 ng/mL have been associated with chronic adverse events including cardiovascular disease. Objective: To conduct a comprehensive population-based study in the United States of the relationship of low and high serum 25(OH)D levels with cardiovascular disease. Methods: We identified all serum 25(OH)D measurements in adults age 18 years and older residing in Olmsted County, MN between January 1, 2005 and December 31, 2011, using the resources of the Rochester Epidemiology Project. Any new diagnosis of cardiovascular disease was the primary outcome, and time zero was 30 days after first 25(OH)D measurement. Patients were followed until their last clinical visit as an Olmsted County resident, December 31, 2014, or death. Categories of 25(OH)D values were examined using predetermined ranges of interest: <12, 12 19, 20 50 (reference range), and >50 ng/mL. Multivariable Cox proportional hazards models were adjusted for age, BMI, sex, race, smoking history, season of 25(OH)D measurement, hypertension, hyperlipidemia, socioeconomic status and Charlson comorbidity index at time of 25(OH)D measurement. Results: A total of 11,002 unique persons had a 25(OH)D measurement, with a mean (+/- SD) value of 30.0 +/- 12.9 ng/mL. Mean age was 54.3 +/- 17.2 years, and the majority were female (77.1 %) and white (87.6 %). There were 4124 new diagnoses of cardiovascular disease in this cohort after a median overall follow-up of 4.8 years (IQR 3.4-6.2). Adjusted cardiovascular disease hazard ratios (HRs) (95 % confidence interval) for 25(OH)D values <12, 12 19, and >50 ng/mL, compared to the reference range 20 50 ng/mL, were 1.28 (1.12-1.46), 1.19 (1.09-1.31), and 1.10 (0.95-1.26), respectively. Conclusion: Values of 25(OH)D <20 ng/mL were associated with development of a new diagnosis of cardiovascular disease. There was no significant association between 25(OH)D values >50 ng/mL and cardiovascular disease.
引用
收藏
页数:8
相关论文
共 38 条
  • [1] Genetically low vitamin D concentrations and increased mortality: mendelian randomisation analysis in three large cohorts
    Afzal, Shoaib
    Brondum-Jacobsen, Peter
    Bojesen, Stig E.
    Nordestgaard, Borge G.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [2] Vitamin D and Cardiovascular Disease Controversy Unresolved
    Al Mheid, Ibhar
    Quyyumi, Arshed A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (01) : 89 - 100
  • [3] Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83000 Individuals in 21 Randomized Clinical Trials: A Meta-analysis
    Barbarawi, Mahmoud
    Kheiri, Babikir
    Zayed, Yazan
    Barbarawi, Owais
    Dhillon, Harsukh
    Swaid, Bakr
    Yelangi, Anitha
    Sundus, Saira
    Bachuwa, Ghassan
    Alkotob, Mohammad Luay
    Manson, JoAnn E.
    [J]. JAMA CARDIOLOGY, 2019, 4 (08) : 765 - 775
  • [4] No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study
    Brondum-Jacobsen, Peter
    Benn, Marianne
    Afzal, Shoaib
    Nordestgaard, Borge G.
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 (02) : 651 - 661
  • [5] 25-Hydroxyvitamin D and Symptomatic Ischemic Stroke: An Original Study and Meta-Analysis
    Brondum-Jacobsen, Peter
    Nordestgaard, Borge G.
    Schnohr, Peter
    Benn, Marianne
    [J]. ANNALS OF NEUROLOGY, 2013, 73 (01) : 38 - 47
  • [6] Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies
    Chowdhury, Rajiv
    Kunutsor, Setor
    Vitezova, Anna
    Oliver-Williams, Clare
    Chowdhury, Susmita
    Kiefte-de-Jong, Jessica C.
    Khan, Hassan
    Baena, Cristina P.
    Prabhakaran, Dorairaj
    Hoshen, Moshe B.
    Feldman, Becca S.
    Pan, An
    Johnson, Laura
    Crowe, Francesca
    Hu, Frank B.
    Franco, Oscar H.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [7] An application of changepoint methods in studying the effect of age on survival in breast cancer
    Contal, C
    O'Quigley, J
    [J]. COMPUTATIONAL STATISTICS & DATA ANALYSIS, 1999, 30 (03) : 253 - 270
  • [8] Serum 25-Hydroxyvitamin D Values and Risk of All-Cause and Cause-Specific Mortality: A Population-Based Cohort Study
    Dudenkov, Daniel V.
    Mara, Kristin C.
    Petterson, Tanya M.
    Maxson, Julie A.
    Thacher, Tom D.
    [J]. MAYO CLINIC PROCEEDINGS, 2018, 93 (06) : 721 - 730
  • [9] Changing Incidence of Serum 25-Hydroxyvitamin D Values Above 50 ng/mL: A 10-Year Population-Based Study
    Dudenkov, Daniel V.
    Yawn, Barbara P.
    Oberhelman, Sara S.
    Fischer, Philip R.
    Singh, Ravinder J.
    Cha, Stephen S.
    Maxson, Julie A.
    Quigg, Stephanie M.
    Thacher, Tom D.
    [J]. MAYO CLINIC PROCEEDINGS, 2015, 90 (05) : 577 - 586
  • [10] Plasma 25-hydroxyvitamin D levels and risk of incident hypertension
    Forman, John P.
    Giovannucci, Edward
    Holmes, Michelle D.
    Bischoff-Ferrari, Heike A.
    Tworoger, Shelley S.
    Willett, Walter C.
    Curhan, Gary C.
    [J]. HYPERTENSION, 2007, 49 (05) : 1063 - 1069